Enjoy our faster App experience

Aramex partners with NewBridge Pharmaceuticals

Aramex partners with NewBridge Pharmaceuticals
Hussein Hachem, CEO of Aramex.

Published: Tue 23 Aug 2016, 6:35 PM

Last updated: Wed 24 Aug 2016, 10:17 AM

Aramex has announced its partnership with NewBridge Pharmaceuticals, under which the company is now providing a range of logistics services for NewBridge in the Middle East, Africa, Canada, and the UK.
Based in Dubai, NewBridge Pharmaceuticals is a regional specialty company providing a one-stop-solution to pharmaceuticals, biological, genomics, and other innovative healthcare companies. The focus is on in-licensing and commercializing FDA and EMA/European approved innovative therapeutics and diagnostics that address unmet medical needs of diseases with high prevalence within the emerging markets of the Middle East and Africa region.
Through the partnership, Aramex is managing the logistics of patient samples across any clinics and hospitals from the Middle East to the US for advanced clinical testing. Aramex is also providing temperature controlled storage and transportation of medication for NewBridge from various distribution hubs in the UK and Canada to healthcare facilities within the Middle East and Africa. Furthermore, Aramex is providing NewBridge with customs clearance, secondary packaging, labeling, vaulting and guarded transport services as part of the partnership.
Hussein Hachem, CEO of Aramex, said: "By working closely with NewBridge we are able to further penetrate the healthcare market, take advantage of the increased demand for logistics services in the pharmaceutical industry, and better support people who require medicine and other pharmaceutical needs to be delivered to them effectively and efficiently. Not only are we proud to be a part of improving peoples' health in the region, but this partnership with NewBridge also attests to the quality and reliability of the logistics services that we provide."
As the global healthcare market continues to develop, regulation and compliance for the transportation and storage of medicine is becoming more stringent. This collaboration between Aramex and NewBridge is consequently filling a gap in the market by ensuring medicines, human specimens, and other pharmaceutical goods are being securely, safely and efficiently transported throughout the region in line with local regulations.
In addition to having facility hubs based in the UK and Canada, Aramex plans to set up a third facility hub in the US soon, and will continue to handle the storage, transport and delivery of NewBridge's medicine and other pharmaceutical goods.
- business@khaleejtimes.com

More news from Business